Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System?

DSpace/Manakin Repository

Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System?

Citable link to this page

 

 
Title: Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System?
Author: Bermudez, Jorge; 't Hoen, Ellen; Moon, Suerie

Note: Order does not necessarily reflect citation order of authors.

Citation: Moon, Suerie, Jorge Bermudez, and Ellen 't Hoen. 2012. Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system? PLoS Medicine 9(5): e1001218.
Full Text & Related Files:
Abstract: As part of a cluster of articles leading up to the 2012 World Health Report and critically reflecting on the theme of “no health without research,” Suerie Moon and colleagues argue for a global health R&D treaty to improve innovation in new medicines and strengthening affordability, sustainable financing, efficiency in innovation, and equitable health-centered governance.
Published Version: doi:10.1371/journal.pmed.1001218
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352855/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10484011
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters